Umbral Energy Corp Share Price Toronto S.E.
Equities
UMB
CA90420Y1088
Pharmaceuticals
Sales 2022 | 29.57 40.29 2.47K | Sales 2023 | 29.79 40.6 2.49K | Capitalization | 14.15M 19.27M 1.18B |
---|---|---|---|---|---|
Net income 2022 | -24M -32.7M -2B | Net income 2023 | -20M -27.25M -1.67B | EV / Sales 2022 | 14,74,984 x |
Net Debt 2022 | 11.54M 15.73M 963M | Net Debt 2023 | 4.53M 6.18M 378M | EV / Sales 2023 | 6,26,876 x |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Jasmine Paige
DFI | Director of Finance/CFO | - | 14/23/14 |
Clinton Sharples
CHM | Chairman | - | 29/13/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clinton Sharples
CHM | Chairman | - | 29/13/29 |
Céline Arsenault
BRD | Director/Board Member | - | 08/19/08 |
Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B |